TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older. It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older. It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

HAE Treatment
Types

There are 2 main types of treatment for hereditary angioedema (HAE). How do you know what’s right for you? Work closely with your doctor when developing your treatment plan and be open and honest about your symptoms and your treatment preferences. Learning as much as you can about treatment can help you prepare to talk to your doctor about what's right for you. Read more below.

Sebastian, a real TAKHZYRO® patient, holding a wood pallet and tools
Sebastian
Icon of chat bubble

Want help talking to your doctor about preventive treatment with TAKHZYRO?

Start your guide

What to know about on-demand treatment

  • On-demand treatment, also known as acute treatment, is medicine used to treat the symptoms of an HAE attack. It’s important to have on-demand treatment available because everyone with HAE is at risk of an attack affecting the airway, which is potentially life-threatening
  • Even if you’re on preventive treatment like TAKHZYRO, you should keep on-demand treatment on hand (and periodically check to make sure it hasn’t expired) so you’re prepared to treat if an attack occurs
  • TAKHZYRO is not on-demand treatment. If you’re interested in learning more about on-demand treatment, you can explore one option here and talk to your doctor
Patient support icon

Attend an HAE event

Educational HAE events are held across the United States. You can hear from an HAE specialist and other people with HAE. See if an event is coming to an area near you!

Explore events

Reimagine dosing and administration

People with HAE are reimagining how often they take preventive treatment with TAKHZYRO.

Explore dosing info

WHAT IS TAKHZYRO?

TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older.

It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

IMPORTANT SAFETY INFORMATION

TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms:

  • wheezing
  • difficulty breathing
  • chest tightness
  • fast heartbeat
  • faintness
  • rash
  • hives

The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, and headache.

These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist. You may report side effects to the FDA at 1-800-FDA-1088.

TAKHZYRO has not been studied in pregnant or breastfeeding women. Talk to your healthcare provider about the risk of taking TAKHZYRO if you are pregnant, plan to be pregnant, are breastfeeding, or plan to breastfeed.

Please see full Prescribing Information, including information for patients.